Literature DB >> 464686

Pathologic identification of poor prognosis stage I (T1N0M0) cancer of the breast.

T F Nealon, A Nkongho, C Grossi, J Gillooley.   

Abstract

Twenty to 40% of Stage I(T1N0M0) cancers of the breast recur in ten years. This is an attempt to identify those patients in whom the disease is likely to recur. On the basis of a study of the histologic changes in the tumor and treatment failures poor prognosis was associated with several histological characteristics: poor cytologic differentiation; lymphatic permeation; blood vessel invasion and invasion of the tumor into the surrounding soft tissue. This classification was then applied to 363 cancers of the breast seen over a five year period and followed three to eight years. There were 203 Stage I (T1N0M0) tumors in the group. Ninety-four of the 203 Stage I tumors had one to four of the above histologic characteristics; 109 had none. Among the 109 patients characterized as good risks there were two treatment failures (2%). In the group of 94 with any high risk histologic features there were 47 treatment failures (50%) which were statistically significant (p = 0.001). The histologic changes had a cumulative effect on the degree of malignancy of the tumor. Pathologic changes in the tumor identified those patients whose Stage I (T1N0M0) tumors were likely to recur.

Entities:  

Mesh:

Year:  1979        PMID: 464686      PMCID: PMC1344476          DOI: 10.1097/00000658-197908000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  Detection and significance of occult axillary node metastases in patients with invasive breast cancer.

Authors:  E R Fisher; S Swamidoss; C H Lee; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

2.  Significance of occult metastases. A study of breast cancer.

Authors:  J W PICKREN
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

3.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases.

Authors:  E R Fisher; A Palekar; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

4.  The analysis and presentation of surgical results by actuarial methods.

Authors:  R P Anderson; L I Bonchek; G L Grunkemeier; L E Lambert; A Starr
Journal:  J Surg Res       Date:  1974-03       Impact factor: 2.192

5.  Long-term followup of breast cancer patients: the 30-year report.

Authors:  F Adair; J Berg; L Joubert; G F Robbins
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

6.  Significance of axillary macrometastases and micrometastases in mammary cancer.

Authors:  A G Huvos; R V Hutter; J W Berg
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

7.  Factors influencing short and long term survival of breast cancer patients.

Authors:  J W Berg; G F Robbins
Journal:  Surg Gynecol Obstet       Date:  1966-06

8.  Survival of patients with carcinoma of breast without lymph node metastases in relation to the tumor types.

Authors:  T I Malinin; G D Lumb
Journal:  J Surg Oncol       Date:  1977       Impact factor: 3.454

  8 in total
  9 in total

1.  Prognosis in node-negative breast cancer.

Authors:  C J van de Velde; H S Gallager; G G Giacco
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

2.  Patients with early breast cancer may be harmed from 'effective' axillary treatment.

Authors:  A N Papaioannou
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 3.  Review of general surgery 1979.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

4.  Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.

Authors:  S Frkovic-Grazio; M Bracko
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

5.  Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.

Authors:  V le Doussal; M Tubiana-Hulin; K Hacene; S Friedman; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

6.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

7.  The DNA labelling index: a prognostic factor in node-negative breast cancer.

Authors:  M Héry; J Gioanni; C M Lalanne; M Namer; A Courdi
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.

Authors:  G G Van den Eynden; I Van der Auwera; S J Van Laere; C G Colpaert; P van Dam; L Y Dirix; P B Vermeulen; E A Van Marck
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

9.  A prognostic score in histological node negative breast cancer.

Authors:  B Chevallier; V Mosseri; J P Dauce; P Bastit; J P Julien; B Asselain
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.